Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Altar


5 rue Henri Desbruères – Genopole Campus 1 – Porte 849
91000 EVRY-COURCOURONNES – FRANCE
Phone : +33 1 60 91 78 88
Email : simon.trancart@altar.bio

Simon TRANCART : Président directeur général
Web Site >

#Biomanufacturing / Pharmaceutical Services #Industrial Biotech #Ag Tech & Green Tech #R&D Services and Products

  • Directed evolution
  • Continuous culture
  • Adaptive laboratory evolution
  • Strain development
  • Natural selection
  • Chemostat, turbidostat, etc.

Field Of Activity


Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

BACKGROUND

Created in 2017, Alter is a biotech company specialized in automated microbial fluidics. The company runs a microorganism adaptive laboratory evolution platform at Genopole for research or propriety projects aimed at developing microorganisms of interest in industry.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

Altar conceives and operates fluidic automated systems for the continuous culture of microbial suspensions. The company’s technology is used mainly in the setting of adaptive evolution experiments aimed at improving microorganism performance via natural selection. It enables the continuous culture of microbial suspensions under algorithm-controlled conditions for as long as is needed. Altar makes its technology and know-how available through collaborative projects or research services.

ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS

Altar has benefited from an independent revenue stream since its creation thanks to the sale of research services to the food, chemistry, biofuels and health industries. The company also receives European subventions as a part of the H2020 eForFuel (www.eforfuel.eu) and SinFonia  projects in partnership with public and private operatives. In 2020, Altar was chosen by the European Commission within the EIC Accelerator Pilot program’s Green Deal call for proposals.

COLLABORATIONS SOUGHT

To sustain its growth, Altar continuously seeks academic and industrial partners to deploy its technology for the development of microbial strains of interest

  • In brief

    Number of employees: 9 employees and currently hiring

    STRENGTHS
    Team, technological leadership, market traction, current growth, independence and agility.

    INNOVATION ASSETS
    A visionary in in vivo adaptive laboratory evolution.

Share
Genopole’s Companies

#Biomanufacturing / Pharmaceutical Services


In same field

Proteinea - Genopole's company

Proteinea

Production as a service (PaaS) platform capable of producing recombinant proteins & enzymes cheaper and on a scale.

Discover
Yubsis - Genopole's company

Yubsis

Yubsis provides Biological Science Information Solutions. Our platform is designed for research organizations willing to improve real-time teamwork, optimize performance and accelerate innovation

Discover
Yposkesi - Genopole's Company

Yposkesi

YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Discover
Watchfrog Laboratory - Genopole's company

WatchFrog

WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Discover
Texcell - Genopole's Company

Texcell

Texcell offers fully GLP- and GMP-compliant viral safety testing and immunomonitoring services.

Discover
Pymabs - Genopole's Company

Pymabs

R & D services in the field of transient expression of recombinant proteins in plants.

Discover
Hybrigenics - Genopole's company

Hybrigenics Services

Hybrigenics Services offers high-quality services to i) discover novel protein interactions, ii) identify the targets of drug candidates and iii) select novel, synthetic single-domain antibodies against any antigen (nanobodies).

Discover
Genosafe - Genopole's Company

Genosafe

GenoSafe is a full contract research and consulting organization specialized in evaluating the quality, safety and efficacy of innovative biological products. Our goal is to enable our clients to move their products along clinical development rapidly and efficiently.

Discover
Eukarÿs - Genopole's company

Eukarÿs

Synthetic gene therapy for the treatment of severe human liver diseases and tools for the bioproduction of recombinant proteins and viruses using the proprietary expression system C3P3.

Discover
ABOLIS - entreprise génopolitaine

Abolis Biotechnologies

Development of custom-order microorganisms able to produce molecules of interest in health, nutrition, cosmetics, chemistry and agriculture.

Discover
View all >
With support